Nutritional therapy for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutr...
Uložené v:
| Vydané v: | World journal of gastrointestinal oncology Ročník 13; číslo 10; s. 1440 |
|---|---|
| Hlavní autori: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
15.10.2021
|
| ISSN: | 1948-5204, 1948-5204 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutritional risk factors also related to HCC development including high intake of saturated fats derived from red meat, type of cooking (generation of heterocyclic amines) and contamination of foods with aflatoxins. On the contrary, protective nutritional factors include diets rich in fiber, fruits and vegetables, n-3 polyunsaturated fatty acids and coffee. While the patient is being evaluated for staging and treatment of HCC, special attention should be paid to nutritional support, including proper nutritional assessment and therapy by a multidisciplinary team. It must be considered that these patients usually develop HCC on top of long-lasting cirrhosis, and therefore they could present with severe malnutrition. Cirrhosis-related complications should be properly addressed and considered for nutritional care. In addition to traditional methods, functional testing, phase angle and computed tomography scan derived skeletal muscle index-L3 are among the most useful tools for nutritional assessment. Nutritional therapy should be centered on providing enough energy and protein to manage the increased requirements of both cirrhosis and cancer. Supplementation with branched-chain amino acids is also recommended as it improves response to treatment, nutritional status and survival, and finally physical exercise must be encouraged and adapted to individual needs.Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutritional risk factors also related to HCC development including high intake of saturated fats derived from red meat, type of cooking (generation of heterocyclic amines) and contamination of foods with aflatoxins. On the contrary, protective nutritional factors include diets rich in fiber, fruits and vegetables, n-3 polyunsaturated fatty acids and coffee. While the patient is being evaluated for staging and treatment of HCC, special attention should be paid to nutritional support, including proper nutritional assessment and therapy by a multidisciplinary team. It must be considered that these patients usually develop HCC on top of long-lasting cirrhosis, and therefore they could present with severe malnutrition. Cirrhosis-related complications should be properly addressed and considered for nutritional care. In addition to traditional methods, functional testing, phase angle and computed tomography scan derived skeletal muscle index-L3 are among the most useful tools for nutritional assessment. Nutritional therapy should be centered on providing enough energy and protein to manage the increased requirements of both cirrhosis and cancer. Supplementation with branched-chain amino acids is also recommended as it improves response to treatment, nutritional status and survival, and finally physical exercise must be encouraged and adapted to individual needs. |
|---|---|
| AbstractList | Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutritional risk factors also related to HCC development including high intake of saturated fats derived from red meat, type of cooking (generation of heterocyclic amines) and contamination of foods with aflatoxins. On the contrary, protective nutritional factors include diets rich in fiber, fruits and vegetables, n-3 polyunsaturated fatty acids and coffee. While the patient is being evaluated for staging and treatment of HCC, special attention should be paid to nutritional support, including proper nutritional assessment and therapy by a multidisciplinary team. It must be considered that these patients usually develop HCC on top of long-lasting cirrhosis, and therefore they could present with severe malnutrition. Cirrhosis-related complications should be properly addressed and considered for nutritional care. In addition to traditional methods, functional testing, phase angle and computed tomography scan derived skeletal muscle index-L3 are among the most useful tools for nutritional assessment. Nutritional therapy should be centered on providing enough energy and protein to manage the increased requirements of both cirrhosis and cancer. Supplementation with branched-chain amino acids is also recommended as it improves response to treatment, nutritional status and survival, and finally physical exercise must be encouraged and adapted to individual needs.Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutritional risk factors also related to HCC development including high intake of saturated fats derived from red meat, type of cooking (generation of heterocyclic amines) and contamination of foods with aflatoxins. On the contrary, protective nutritional factors include diets rich in fiber, fruits and vegetables, n-3 polyunsaturated fatty acids and coffee. While the patient is being evaluated for staging and treatment of HCC, special attention should be paid to nutritional support, including proper nutritional assessment and therapy by a multidisciplinary team. It must be considered that these patients usually develop HCC on top of long-lasting cirrhosis, and therefore they could present with severe malnutrition. Cirrhosis-related complications should be properly addressed and considered for nutritional care. In addition to traditional methods, functional testing, phase angle and computed tomography scan derived skeletal muscle index-L3 are among the most useful tools for nutritional assessment. Nutritional therapy should be centered on providing enough energy and protein to manage the increased requirements of both cirrhosis and cancer. Supplementation with branched-chain amino acids is also recommended as it improves response to treatment, nutritional status and survival, and finally physical exercise must be encouraged and adapted to individual needs. |
| Author | Moreno-Guillén, Paulina Ruiz-Margáin, Astrid González-Regueiro, José A Campos-Murguía, Alejandro Román-Calleja, Berenice M Flores-García, Nayelli C Kúsulas-Delint, Deyanira Macías-Rodríguez, Ricardo Ulises |
| Author_xml | – sequence: 1 givenname: Astrid surname: Ruiz-Margáin fullname: Ruiz-Margáin, Astrid – sequence: 2 givenname: Berenice M surname: Román-Calleja fullname: Román-Calleja, Berenice M – sequence: 3 givenname: Paulina surname: Moreno-Guillén fullname: Moreno-Guillén, Paulina – sequence: 4 givenname: José A surname: González-Regueiro fullname: González-Regueiro, José A – sequence: 5 givenname: Deyanira surname: Kúsulas-Delint fullname: Kúsulas-Delint, Deyanira – sequence: 6 givenname: Alejandro surname: Campos-Murguía fullname: Campos-Murguía, Alejandro – sequence: 7 givenname: Nayelli C surname: Flores-García fullname: Flores-García, Nayelli C – sequence: 8 givenname: Ricardo Ulises surname: Macías-Rodríguez fullname: Macías-Rodríguez, Ricardo Ulises |
| BookMark | eNpNjj9PwzAUxC1UJErpB2DLyJLwbD-n8Ygq_kkVLDBXz45NU6VxsR0Q354gGLjlTj-dTnfOZkMYHGOXHCoUil9_7t9C9cFl1U2EI8IJm3ONTakE4OxfPmPLlPYwCXEFHOYMnsYcu9yFgfoi71yk41fhQyx27kg5WNf3Y0-xsBRtN4QDXbBTT31yyz9fsNe725f1Q7l5vn9c32xKiyhyqRuQNVjrdW2ckl6RqcGTMcLwRpKs2xW2rZpq1njrFOnWT6ixAmoD4MSCXf3uHmN4H13K20OXfu7Q4MKYtkJpLiSg1OIbeGlMfw |
| CitedBy_id | crossref_primary_10_1186_s12876_024_03438_x crossref_primary_10_3390_genes16080920 crossref_primary_10_3390_nu15153487 crossref_primary_10_1002_cam4_70914 crossref_primary_10_1080_01635581_2024_2378504 crossref_primary_10_1155_2022_1342773 crossref_primary_10_4240_wjgs_v17_i2_101297 crossref_primary_10_1200_OP_24_00872 crossref_primary_10_2147_JHC_S414789 crossref_primary_10_3390_cancers16051030 crossref_primary_10_3390_livers3020013 crossref_primary_10_1007_s00423_023_03170_2 crossref_primary_10_1038_s41423_025_01308_4 crossref_primary_10_3390_diagnostics14040371 crossref_primary_10_3389_fonc_2022_947302 crossref_primary_10_2147_JIR_S424384 crossref_primary_10_3389_fcell_2022_1051306 crossref_primary_10_1097_MCO_0000000000000998 crossref_primary_10_4240_wjgs_v16_i8_2409 crossref_primary_10_4240_wjgs_v17_i6_104883 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Copyright_xml | – notice: The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| DBID | 7X8 |
| DOI | 10.4251/wjgo.v13.i10.1440 |
| DatabaseName | MEDLINE - Academic |
| DatabaseTitle | MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1948-5204 |
| GroupedDBID | 53G 5VR 7X8 8WL AAKDD ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CCEZO CHBEP CIEJG CW9 DIK E3Z F5P GX1 HYE OK1 RNS RPM |
| ID | FETCH-LOGICAL-c442t-980360ccf96be53f5ab60fabb2b183a36d74dd5980cbfce5a9dfd748c206b00e2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 26 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000721601200014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1948-5204 |
| IngestDate | Sun Nov 09 13:21:46 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c442t-980360ccf96be53f5ab60fabb2b183a36d74dd5980cbfce5a9dfd748c206b00e2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://doi.org/10.4251/wjgo.v13.i10.1440 |
| PQID | 2591230439 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2591230439 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-10-15 |
| PublicationDateYYYYMMDD | 2021-10-15 |
| PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationTitle | World journal of gastrointestinal oncology |
| PublicationYear | 2021 |
| SSID | ssj0000447010 |
| Score | 2.310581 |
| SecondaryResourceType | review_article |
| Snippet | Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized... |
| SourceID | proquest |
| SourceType | Aggregation Database |
| StartPage | 1440 |
| Title | Nutritional therapy for hepatocellular carcinoma |
| URI | https://www.proquest.com/docview/2591230439 |
| Volume | 13 |
| WOSCitedRecordID | wos000721601200014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UinjxLb6J4HXbTTLZx0lELB60eFDorezTB5iorRX_vbNJqgcvgpBTMpBldx5fvpnMEHJiDICTvKA6CE7BGUa1kI6qTONlLVhf95m9EoOBHA7VTUu4jduyyplPrB21q2zkyHsI09NIYObq9OWVxqlRMbvajtCYJ50coUzUajGU3xwLAxCsaUigQOI3F4MmsYmKmvY-nu6r7jTNu4_RcwCwX-64jjH91f-ubo2stOgyOWvUYZ3M-XKDLF23-fNNwgaz5vso1fx69ZkgbE0eMCpNqsjix7LUxMYJQ2X1rLfIXf_i9vyStjMTqAXIJlRJDEnM2qC48UUeCm04C9qYzKDx6pw7Ac4VKGZNsL7QygW8JW3GOFqgz7bJQlmVfofgq0IqAwfFnYJCW41QIA-OC4OYBp_tkuPZXoxQJ-MSdemr9_HoZzf2_iCzT5azWCgSy0SKA9IJaHf-kCza6eRx_HZUH-kXjg2sMw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nutritional+therapy+for+hepatocellular+carcinoma&rft.jtitle=World+journal+of+gastrointestinal+oncology&rft.au=Ruiz-Marg%C3%A1in%2C+Astrid&rft.au=Rom%C3%A1n-Calleja%2C+Berenice+M&rft.au=Moreno-Guill%C3%A9n%2C+Paulina&rft.au=Gonz%C3%A1lez-Regueiro%2C+Jos%C3%A9+A&rft.date=2021-10-15&rft.issn=1948-5204&rft.eissn=1948-5204&rft.volume=13&rft.issue=10&rft.spage=1440&rft_id=info:doi/10.4251%2Fwjgo.v13.i10.1440&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1948-5204&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1948-5204&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1948-5204&client=summon |